274 related articles for article (PubMed ID: 23184534)
21. Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide.
Hatahet T; Morille M; Shamseddin A; Aubert-Pouëssel A; Devoisselle JM; Bégu S
Int J Pharm; 2017 Feb; 518(1-2):167-176. PubMed ID: 28011344
[TBL] [Abstract][Full Text] [Related]
22. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
23. A miniemulsion polymerization technique for encapsulation of silicon quantum dots in polymer nanoparticles.
Harun NA; Horrocks BR; Fulton DA
Nanoscale; 2011 Nov; 3(11):4733-41. PubMed ID: 21984383
[TBL] [Abstract][Full Text] [Related]
24. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
[TBL] [Abstract][Full Text] [Related]
25. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis.
Liu C; Yu W; Chen Z; Zhang J; Zhang N
J Control Release; 2011 Apr; 151(2):162-75. PubMed ID: 21376765
[TBL] [Abstract][Full Text] [Related]
26. Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro.
Zheng X; Kan B; Gou M; Fu S; Zhang J; Men K; Chen L; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
Int J Pharm; 2010 Feb; 386(1-2):262-7. PubMed ID: 19932160
[TBL] [Abstract][Full Text] [Related]
27. Fusiform micelles from nonlinear poly(ethylene glycol)/polylactide copolymers as biodegradable drug carriers.
Li T; Han R; Wang M; Liu C; Jing X; Huang Y
Macromol Biosci; 2011 Nov; 11(11):1570-8. PubMed ID: 22167874
[TBL] [Abstract][Full Text] [Related]
28. Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies.
Hädrich G; Monteiro SO; Rodrigues MR; de Lima VR; Putaux JL; Bidone J; Teixeira HF; Muccillo-Baisch AL; Dora CL
Drug Dev Ind Pharm; 2016; 42(7):1165-73. PubMed ID: 26571009
[TBL] [Abstract][Full Text] [Related]
29. Anti-cancer evaluation of quercetin embedded PLA nanoparticles synthesized by emulsified nanoprecipitation.
Pandey SK; Patel DK; Thakur R; Mishra DP; Maiti P; Haldar C
Int J Biol Macromol; 2015 Apr; 75():521-9. PubMed ID: 25701491
[TBL] [Abstract][Full Text] [Related]
30. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
31. Silicon Quantum Dot Nanoparticles with Antifouling Coatings for Immunostaining on Live Cancer Cells.
Tu CC; Chen KP; Yang TA; Chou MY; Lin LY; Li YK
ACS Appl Mater Interfaces; 2016 Jun; 8(22):13714-23. PubMed ID: 27198164
[TBL] [Abstract][Full Text] [Related]
32. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
[TBL] [Abstract][Full Text] [Related]
33. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
34. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
35. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
[TBL] [Abstract][Full Text] [Related]
36. Development of biodegradable nanoparticles for delivery of quercetin.
Kumari A; Yadav SK; Pakade YB; Singh B; Yadav SC
Colloids Surf B Biointerfaces; 2010 Oct; 80(2):184-92. PubMed ID: 20598513
[TBL] [Abstract][Full Text] [Related]
37. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
38. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
39. Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9.
Kumar M; Gupta D; Singh G; Sharma S; Bhat M; Prashant CK; Dinda AK; Kharbanda S; Kufe D; Singh H
Cancer Res; 2014 Jun; 74(12):3271-81. PubMed ID: 24741005
[TBL] [Abstract][Full Text] [Related]
40. In vitro cytotoxicity, hemolysis assay, and biodegradation behavior of biodegradable poly(3-hydroxybutyrate)-poly(ethylene glycol)-poly(3-hydroxybutyrate) nanoparticles as potential drug carriers.
Chen C; Cheng YC; Yu CH; Chan SW; Cheung MK; Yu PH
J Biomed Mater Res A; 2008 Nov; 87(2):290-8. PubMed ID: 18181106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
